My name is Patricia Martins Bock, and I am a Professor and Researcher at the Department of Physiology of the Federal University of Rio Grande do Sul (UFRGS, Brazil). I am a Pharmacist, hold a PhD in Physiology, and my research focuses on diabetes mellitus, hypertension, and cardiovascular diseases, with a special interest in non-pharmacological interventions and translational approaches integrating clinical, preclinical, and applied research.
Over the years, my work has contributed to advancing the understanding of cellular and molecular mechanisms involved in metabolic and cardiovascular disorders, while also generating evidence with direct relevance for clinical practice and public health strategies. I am particularly interested in the role of the gut microbiota, probiotics, prebiotics, and microbiota-derived metabolites in metabolic and cardiometabolic health.
I value collaborative and interdisciplinary research networks that connect physiology, pharmacology, metabolism, gut microbiota, diabetes, and cardiovascular health. I hope my work can support researchers and healthcare professionals in developing innovative strategies to prevent and manage metabolic diseases and their complications.
I am a member of the Brazilian Diabetes Society and the Brazilian Society of Pharmacology and Experimental Therapeutics.
My name is Patricia Martins Bock, and I am a Professor and Researcher at the Department of Physiology of the Federal University of Rio Grande do Sul (UFRGS, Brazil). I am a Pharmacist, hold a PhD in Physiology, and my research focuses on diabetes mellitus, hypertension, and cardiovascular diseases, with a special interest in non-pharmacological interventions and translational approaches integrating clinical, preclinical, and applied research.
Over the years, my work has contributed to advancing the understanding of cellular and molecular mechanisms involved in metabolic and cardiovascular disorders, while also generating evidence with direct relevance for clinical practice and public health strategies. I am particularly interested in the role of the gut microbiota, probiotics, prebiotics, and microbiota-derived metabolites in metabolic and cardiometabolic health.
I value collaborative and interdisciplinary research networks that connect physiology, pharmacology, metabolism, gut microbiota, diabetes, and cardiovascular health. I hope my work can support researchers and healthcare professionals in developing innovative strategies to prevent and manage metabolic diseases and their complications.
I am a member of the Brazilian Diabetes Society and the Brazilian Society of Pharmacology and Experimental Therapeutics.